Euroapi

Euroapi Long-term Debt

The Long-Term Debt of Euroapi (EAPI.PA) as of Oct 16, 2026 is 16.30 M EUR. In the previous year, Long-Term Debt was 13.20 M EUR — a change of 23.48% (higher).

Long-term Debt

16.30 MEUR

YoY

23.48%

Last updated:

Long-Term Debt of Euroapi is 2025 16.30 M EUR. Long-Term Debt of Euroapi was 2024 13.20 M EUR. It decreases by 23.48% higher compared to the previous year.

The Euroapi Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2019
17.80 M EUR
Jan 1, 2020
15.40 M EUR
Jan 1, 2021
18.70 M EUR
Jan 1, 2022
16.20 M EUR
Jan 1, 2023
15.50 M EUR
Jan 1, 2024
13.20 M EUR
Jan 1, 2025
16.30 M EUR
The Euroapi Long-term Debt history
YEARLong-term DebtYoY
16.30 MEUR+23.48%
13.20 MEUR-14.84%
15.50 MEUR-4.32%
16.20 MEUR-13.37%
18.70 MEUR+21.43%
15.40 MEUR-13.48%
17.80 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Euroapi Stock analysis

What does Euroapi do? Euroapi SA, listed on EAPI.PA with ISIN FR0014008VX5, is a pharmaceutical company headquartered in Paris, France. The company went public on May 6, 2022, and currently employs 3,449 full-time staff. Euroapi specializes in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) for healthcare partners. Its product portfolio includes vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids, hormones, anti-infectives, opiates such as morphine, codeine, and thebaine, and analgesics. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering services such as Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones, and Opiates & Controlled Substances. Euroapi maintains production facilities across multiple European countries, including France, the United Kingdom, Germany, Italy, and Hungary. The company's website is www.euroapi.com, where further information about its services and operations can be found. Euroapi focuses on providing tailored API solutions to support the pharmaceutical industry's needs, emphasizing its role in the healthcare sector through its specialized manufacturing capabilities. Euroapi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Euroapi stock

Long-Term Debt of Euroapi is 16.30 M EUR in 2025.

Long-Term Debt of Euroapi changed from 13.20 M EUR to 16.30 M EUR, representing a 23.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Euroapi since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Euroapi historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Euroapi

All Key Metrics — Euroapi